University of Colorado, Boulder
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Colorado, Boulder sits in the top decile of US sponsors by registered trial count (#307 of 15,742 sponsors by registered trial count).
University of Colorado, Boulder: 69 sponsored US clinical trials, 15 recruiting.
University of Colorado, Boulder sponsors 69 registered US clinical trials on ClinicalTrials.gov, 15 of them currently recruiting, and 48 completed. 3 of these trials are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Aging, with 4 trials.
Top-decile sponsor footprint
University of Colorado, Boulder ranks in the top decile of sponsors by registered trial count (#307 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
48 of 49 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (98.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
69 total, page 2 of 2
Perinatal Emotion and Relationships Longitudinal Study
NCT03027037
The Microbiome and Resilience to Sleep and Circadian Disruption
NCT03747367
The Efficacy of Oral Mitoquinone (MitoQ) Supplementation for Improving Physiological in Middle-aged and Older Adults
NCT02597023
Acceptance and Commitment Therapy (ACT) for Anxious Cancer Survivors
NCT02550925
Safety & Efficacy of Nicotinamide Riboside Supplementation for Improving Physiological Function in Middle-Aged and Older Adults
NCT02921659
Nitrite Supplementation for Improving Physiological Function in Older Adults
NCT02393742
Exercise and Markers of Medial Temporal Health in Youth At-risk for Psychosis
NCT02155699
Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis
NCT02152085
Enhancing Function in Later Life: Exercise and Functional Network Connectivity
NCT02068612
DNA Methylation and Cancer Prevention: Duration and Intensity of Exercise
NCT02032628
Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults
NCT01575288
Nebivolol and Endothelial Regulation of Fibrinolysis (NERF)
NCT01595516
Sodium Nitrite to Treat Arterial Aging
NCT02022670
Nebivolol and the Endothelin (ET)-1 System
NCT01395329
Mindfulness-Based Cognitive Therapy for the Prevention of Perinatal Depressive Relapse/Recurrence
NCT02387424
Efficacy of Dietary Sodium Restriction of Improving Vascular Endothelial Function in Middle Aged and Older Adults
NCT01566084
The Staying Well Study: An Open Trial of Mindfulness-Based Cognitive Therapy for the Prevention of Perinatal Depression
NCT02391870
A Dose Response Effect of Atomoxetine to the Acute Effects of Alcohol
NCT01408589
Efficacy of Voice Treatment for Parkinson's Disease
NCT00123084
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 4 |
| Phase 4 | 3 |
Therapeutic Areas
What is open in the University of Colorado, Boulder pipeline
15 recruiting of 69 indexed (22% open); 48 completed (70%).
Phase mix: 3 late (III/IV) vs 9 early (I/II) (early-phase heavy).
Top condition: Aging (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Colorado, Boulder: open-pipeline peers nationwide
Peers matched on 69 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
University of Colorado, Boulder sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 69 trials (± recruiting share)
- Mallinckrodt · 69 trials · 0% recruiting
- Providence Health & Services · 69 trials · 7% recruiting
- Texas Tech University · 69 trials · 17% recruiting
- Procter and Gamble · 70 trials · 0% recruiting
Sponsors near 22% open enrollment (± trial volume)
- AtriCure · 22% recruiting · 23 trials
- University of Maryland, College Park · 22% recruiting · 46 trials
- Regeneron Pharmaceuticals · 22% recruiting · 280 trials
- Henry M. Jackson Foundation for the Advancement of Military Medicine · 22% recruiting · 60 trials
Related
What to do with this University of Colorado, Boulder page
69 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Boulder or any single study.
- 15 of University of Colorado, Boulder's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Aging is the condition University of Colorado, Boulder studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aging trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Colorado, Boulder pipeline card: 69 registered trials from official public datasets.Report a data error.